• June 2008

Imaging3, Inc is proud to include you in our inaugural newsletter. Imaging3, Inc., (OTCBB:IMGG), a public company trading on the over the counter bulletin board under the NASD trading symbol IMGG.OB, is the developer of a patented and breakthrough technology the Dominion Vi Scanner. This revolutionary technology produces 3D medical diagnostic images of virtually any part of the human body in real-time.  We are proud as well of our recent award from the prestigious research organization, Frost & Sullivan, which awarded the Dominion Vi Scanner the “2008 North American Medical Imaging Product Innovation of the Year”. Other recent news includes the FDA’s approval to distribute the Dominion Vi Scanner under FDA (IDE) regulations, with full approval expected in the very near future.

Please take the time to view all of our recent and current events by visiting our website, www.imaging3.com. You may also wish to share this exciting news and technology with friends, colleagues and relatives as well and have them register for our newsletter on our website. We will be updating you as new developments occur and as we transition through this exciting time moving from a development company to a production company. Our newsletter will be distributed approximately once a week or as any new developments occur.  Should you have any questions or comments you should contact Mike Nessen, Vice President of Business Development, mike@imaging3.com  or my Executive Assistant Becky Krames becky@imaging3.com .


Sincerely,

Dean Janes, Chairman/CEO
Imaging3, Inc
3200 W. Valhalla Drive
Burbank, CA  91505
(800)900-9729
(818)260-0445 Fax
http://www.imaging3.com



Safe Harbor Statement

Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.